References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Dixonetal(1990)Requirementofa5-lipoxygenase-activatingproteinforleukotrienesynthesis.Nature343282PMID:2300173
Gillardetal(1989)L-663,536(MK-886)(3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoicacid),anovel,orallyactiveleukotrienebiosynthesisinhibitor.Can.J.Physiol.Pharmacol.67456PMID:2548691
Kehreretal(2001)Inhibitionofperoxisome-proliferator-activatedreceptor(PPAR)αbyMK886.Biochem.J.356899PMID:11389700
Mancinietal(1992)5-Lipoxygenase-activatingproteinisthetargetofanovelhybridoftwoclassesofleukotrienebiosynthesisinhibitors.Mol.Pharmacol.41267PMID:1538707
Keywords:MK886,supplier,Inhibitor,5-lipoxygenase-activating,protein,FLAP,PPARα,PPARalpha,antagonists,inhibitors,inhibits,Oxygenases,Oxidases,leukotrienes,eicosanoids,biosynthesis,Peroxisome,Proliferator-activated,PPARs,MK886,L663536,5-LOX,L-663,536,Lipoxygenase,PPARalpha,Receptors,Leukotriene,and,Related,Receptors,Lipoxygenase,TocrisBioscience